Drug
ertugliflozin and sitagliptin
Marketed as STEGLUJAN.
Generic name
ertugliflozin and sitagliptin
Brand names
STEGLUJAN
First FDA approval
2017-12-19
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA209805 | STEGLUJAN | 2017-12-19 | MSD SUB MERCK |
Manufacturers
MSD SUB MERCK
Frequently asked questions
When was ertugliflozin and sitagliptin FDA approved?
Earliest FDA approval on record: 2017-12-19.
What brand names are sold as ertugliflozin and sitagliptin?
STEGLUJAN.
Sources
Appeal a ertugliflozin and sitagliptin denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com